| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Medical Research Council Trauma Group, North West Injury Research Center, University of Manchester, Hope Hospital, Salford, United Kingdom M6 8HD
Address all correspondence and requests for reprints to: Dr. Gordon L. Carlson, Medical Research Council Trauma Group, Clinical Sciences Building, Hope Hospital, Salford, United Kingdom M6 8HD. E-mail: gcarlson{at}fs1.ho.man.ac.uk
Infection results in a state of insulin resistance, but the pathogenesis is poorly understood. Intravenous administration of bacterial lipopolysaccharide (LPS) has been used to mimic the febrile and systemic inflammatory responses to infection, but it is unclear whether LPS induces insulin resistance in man. To investigate the effects of LPS on insulin sensitivity and substrate utilization, we administered, in paired cross-over studies, either 20 U/kg Escherichia coli endotoxin or saline control to healthy volunteers (n = 6) 120 min after the start of a 10-h euglycemic hyperinsulinemic clamp (insulin infusion rate, 80 mU/m2·min). LPS induced a fever, tachycardia, and mild arterial hypotension. Glucose utilization increased abruptly 120 min after LPS administration (+64.1 ± 12.0%; P < 0.003), but then declined progressively, and insulin resistance was evident by 420 min (+1.9 ± 3.5%; P < 0.05). The reduction in glucose utilization, like that observed in sepsis, was related to impaired nonoxidative glucose disposal and not abnormal glucose oxidation. The cortisol and GH responses to LPS were of sufficient duration and magnitude to explain the insulin resistance. LPS administration results in metabolic responses very similar to those observed in sepsis and could provide a useful model for the study of insulin resistance in human critical illness.
This article has been cited by other articles:
 |
|
 |
|
  A. Shah, N. Mehta, and M. P. Reilly Adipose Inflammation, Insulin Resistance, and Cardiovascular Disease JPEN J Parenter Enteral Nutr, November 1, 2008; 32(6): 638 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Banks, S. Dohgu, J. L. Lynch, M. A. Fleegal-DeMotta, M. A. Erickson, R. Nakaoke, and T. Q. Vo Nitric Oxide Isoenzymes Regulate Lipopolysaccharide-Enhanced Insulin Transport across the Blood-Brain Barrier Endocrinology, April 1, 2008; 149(4): 1514 - 1523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. O. Badellino, M. L. Wolfe, M. P. Reilly, and D. J. Rader Endothelial Lipase Is Increased In Vivo by Inflammation in Humans Circulation, February 5, 2008; 117(5): 678 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bahador and A. S. Cross Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects Innate Immunity, October 1, 2007; 13(5): 251 - 279. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Vila, C. Maier, M. Riedl, P. Nowotny, B. Ludvik, A. Luger, and M. Clodi Bacterial Endotoxin Induces Biphasic Changes in Plasma Ghrelin in Healthy Humans J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3930 - 3934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Anderson, N. N. Mehta, M. L. Wolfe, C. C. Hinkle, L. Pruscino, L. L. Comiskey, J. Tabita-Martinez, K. F. Sellers, M. R. Rickels, R. S. Ahima, et al. Innate Immunity Modulates Adipokines in Humans J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2272 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Orellana, S. R. Kimball, A. Suryawan, J. Escobar, H. V. Nguyen, L. S. Jefferson, and T. A. Davis Insulin stimulates muscle protein synthesis in neonates during endotoxemia despite repression of translation initiation Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E629 - E636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. del Rey, E. Roggero, A. Randolf, C. Mahuad, S. McCann, V. Rettori, and H. O. Besedovsky IL-1 resets glucose homeostasis at central levels PNAS, October 24, 2006; 103(43): 16039 - 16044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Orellana, P. M. J. O'Connor, J. A. Bush, A. Suryawan, M. C. Thivierge, H. V. Nguyen, M. L. Fiorotto, and T. A. Davis Modulation of muscle protein synthesis by insulin is maintained during neonatal endotoxemia Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E159 - E166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Reilly, M. Lehrke, M. L. Wolfe, A. Rohatgi, M. A. Lazar, and D. J. Rader Resistin Is an Inflammatory Marker of Atherosclerosis in Humans Circulation, February 22, 2005; 111(7): 932 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Lazar How Obesity Causes Diabetes: Not a Tall Tale Science, January 21, 2005; 307(5708): 373 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Jeschke, D. Klein, U. Bolder, and R. Einspanier Insulin Attenuates the Systemic Inflammatory Response in Endotoxemic Rats Endocrinology, September 1, 2004; 145(9): 4084 - 4093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dandona, A. Aljada, A. Chaudhuri, and A. Bandyopadhyay The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2422 - 2429. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Orellana, P. M. J. O'Connor, H. V. Nguyen, J. A. Bush, A. Suryawan, M. C. Thivierge, M. L. Fiorotto, and T. A. Davis Endotoxemia reduces skeletal muscle protein synthesis in neonates Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E909 - E916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Soop, H. Duxbury, A. O Agwunobi, J. M. Gibson, S. J. Hopkins, C. Childs, R. G. Cooper, P. Maycock, R. A. Little, and G. L. Carlson Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1276 - E1285. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
